论文部分内容阅读
自 1 998年 5月～ 1 999年 1月 ,我院应用黑龙江迪龙制药有限公司生产的灯盏花素注射液治疗急性脑梗死患者 84例 ,结果显示灯盏花素组在临床疗效及改善血液流变学和微循环等方面均优于川芎嗪组 ,现将临床观察结果报告如下。1 资料与方法1 .1 病例选择 84例急性脑梗死患者均
From May 1998 to January 1999, our hospital applied Breviscapine Injection produced by Heilongjiang Dilong Pharmaceutical Co., Ltd. to treat 84 patients with acute cerebral infarction. The results showed that the Breviscapin group has clinical efficacy and improved blood flow Change and microcirculation, etc. are better than tetramethylpyrazine group, the clinical observations are reported as follows. 1 Materials and Methods 1.1 cases of 84 patients with acute cerebral infarction were selected